{
  "image_filename": "table_p4_det_3_003.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p4_det_3_003.png",
  "image_type": "Table",
  "page_number": 4,
  "block_id": "det_3_003",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table showing pre- and post-vaccination immunogenicity results (% response, GMTs) for placebo and various Flublok cohorts (overall Flublok, previously vaccinated (PV), and not previously vaccinated (NPV)), with sample sizes and confidence intervals. does not support the claim because the table presents data comparing Flublok against placebo and subgroups of Flublok recipients but contains no data on Fluarix or a standard-dose quadrivalent comparator Note: Table is partially visible but clearly lists only placebo and Flublok arms; no mention of Fluarix",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table showing pre- and post-vaccination immunogenicity results (% response, GMTs) for placebo and various Flublok cohorts (overall Flublok, previously vaccinated (PV), and not previously vaccinated (NPV)), with sample sizes and confidence intervals.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table presents data comparing Flublok against placebo and subgroups of Flublok recipients but contains no data on Fluarix or a standard-dose quadrivalent comparator",
    "confidence_notes": "Table is partially visible but clearly lists only placebo and Flublok arms; no mention of Fluarix"
  }
}